StockData
PBMNasdaqPharmaceutical PreparationsFiscal year ends March 31Also trades as PBMWW

PSYENCE BIOMEDICAL LTD.

Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jun 22, 2026
$4.12−0.10 (-2.37%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

PSYENCE BIOMEDICAL LTD. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Psyence Biomedical does not break out revenue by segment, region or product in the tagged data of its filings for this period type.